Chemical Compound Review:
MMI270 (2R)-N-hydroxy-2-[(4- methoxyphenyl)sulfony...
Synonyms:
CHEMBL267178, CGS-27023A, AC1L9JQY, DNC000955, DNC010718, ...
Kopka,
Breyholz,
Wagner,
Law,
Riemann,
Schröer,
Trub,
Guilbert,
Levkau,
Schober,
Schäfers,
Prescott,
Sawyer,
Von Linden-Reed,
Jeune,
Chou,
Caplan,
Jeng,
Ganu,
Melton,
Wang,
Roberts,
DiMicco,
Patwari,
Siparsky,
Kumar,
Pratta,
Lark,
Kim,
Grodzinsky,
Yoshiizumi,
Yamamoto,
Miyasaka,
Ito,
Kumihara,
Sawa,
Kiyoi,
Yamamoto,
Nakajima,
Hirayama,
Kondo,
Ishibushi,
Ohmoto,
Inoue,
Yoshino,
Eskens,
Levitt,
Sparreboom,
Choi,
Mather,
Verweij,
Harris,
- Effect of matrix metalloproteinase inhibition on progression of atherosclerosis and aneurysm in LDL receptor-deficient mice overexpressing MMP-3, MMP-12, and MMP-13 and on restenosis in rats after balloon injury. Prescott, M.F., Sawyer, W.K., Von Linden-Reed, J., Jeune, M., Chou, M., Caplan, S.L., Jeng, A.Y. Ann. N. Y. Acad. Sci. (1999)
- Oral administration of a matrix metalloproteinase inhibitor, CGS 27023A, protects the cartilage proteoglycan matrix in a partial meniscectomy model of osteoarthritis in rabbits. O'Byrne, E.M., Parker, D.T., Roberts, E.D., Goldberg, R.L., MacPherson, L.J., Blancuzzi, V., Wilson, D., Singh, H.N., Ludewig, R., Ganu, V.S. Inflamm. Res. (1995)
- Synthesis and preliminary biological evaluation of new radioiodinated MMP inhibitors for imaging MMP activity in vivo. Kopka, K., Breyholz, H.J., Wagner, S., Law, M.P., Riemann, B., Schröer, S., Trub, M., Guilbert, B., Levkau, B., Schober, O., Schäfers, M. Nucl. Med. Biol. (2004)
- Mechanisms and kinetics of glycosaminoglycan release following in vitro cartilage injury. DiMicco, M.A., Patwari, P., Siparsky, P.N., Kumar, S., Pratta, M.A., Lark, M.W., Kim, Y.J., Grodzinsky, A.J. Arthritis Rheum. (2004)
- Inhibition of interleukin-1alpha-induced cartilage oligomeric matrix protein degradation in bovine articular cartilage by matrix metalloproteinase inhibitors: potential role for matrix metalloproteinases in the generation of cartilage oligomeric matrix protein fragments in arthritic synovial fluid. Ganu, V., Goldberg, R., Peppard, J., Rediske, J., Melton, R., Hu, S.I., Wang, W., Duvander, C., Heinegård, D. Arthritis Rheum. (1998)
- Effect of food on the pharmacokinetics of oral MMI270B (CGS 27023A), a novel matrix metalloproteinase inhibitor. Eskens, F.A., Levitt, N.C., Sparreboom, A., Choi, L., Mather, R., Verweij, J., Harris, A.L. Clin. Cancer Res. (2000)
- Functional role of matrix metalloproteinases (MMPs) in mammary epithelial cell development. Lee, P.P., Hwang, J.J., Mead, L., Ip, M.M. J. Cell. Physiol. (2001)
- Functional significance of MMP-9 in tumor necrosis factor-induced proliferation and branching morphogenesis of mammary epithelial cells. Lee, P.P., Hwang, J.J., Murphy, G., Ip, M.M. Endocrinology (2000)
- NMR solution structure of the catalytic fragment of human fibroblast collagenase complexed with a sulfonamide derivative of a hydroxamic acid compound. Moy, F.J., Chanda, P.K., Chen, J.M., Cosmi, S., Edris, W., Skotnicki, J.S., Wilhelm, J., Powers, R. Biochemistry (1999)
- Matrix metalloproteinase inhibitor CGS 27023A protects COMP and proteoglycan in the bovine articular cartilage but not the release of their fragments from cartilage after prolonged stimulation in vitro with IL-1 alpha. Ganu, V., Melton, R., Wang, W., Roberts, D. Ann. N. Y. Acad. Sci. (1999)
- Synthesis and structure-activity relationships of 5,6,7,8-tetrahydropyrido[3,4-b]pyrazine-based hydroxamic acids as HB-EGF shedding inhibitors. Yoshiizumi, K., Yamamoto, M., Miyasaka, T., Ito, Y., Kumihara, H., Sawa, M., Kiyoi, T., Yamamoto, T., Nakajima, F., Hirayama, R., Kondo, H., Ishibushi, E., Ohmoto, H., Inoue, Y., Yoshino, K. Bioorg. Med. Chem. (2003)